Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: April 30, 2021 Report Code: GDME1114EPD-ST

Select Item

Arteriotomy closure devices are used to achieve the hemostasis of an arterial puncture site after an angiography procedure, percutaneous coronary intervention or a peripheral intervention. GlobalData's Medical Devices sector report, “Arteriotomy Closure Devices – Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Arteriotomy Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Arteriotomy Closure Devices Pipeline Landscape report provides key information and data related to:
Extensive coverage of the Arteriotomy Closure Devices under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Arteriotomy Closure Devices pipeline products.
Review of Recent Developments in the segment / industry
The Arteriotomy Closure Devices Pipeline Landscape report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Glaucoma Drainage Device sunder development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
The major companies covered in the “Arteriotomy Closure Devices – Medical Devices Pipeline Product Landscape, 2021” report:
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

Extensive coverage of the Arteriotomy Closure Devices under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Arteriotomy Closure Devices under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product’s current stage of development, territory and estimated launch date

Aporo Biomedical
Inc. (Inactive)
CardioDex Ltd (Inactive)
CloSys Corp
CPC of America Inc
Dextera Surgical Inc
Harvard University
Mayo Clinic
ProMed Inc
Rex Medical LP
University of Rochester
Vascular Closure Systems Inc
Venock Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 4

|1.2 List of Figures 6

2 Introduction 7

2.1 Arteriotomy Closure Devices Overview 7

3 Products under Development 8

3.1 Arteriotomy Closure Devices – Pipeline Products by Stage of Development 8

3.2 Arteriotomy Closure Devices – Pipeline Products by Segment 9

3.3 Arteriotomy Closure Devices – Pipeline Products by Territory 10

3.4 Arteriotomy Closure Devices – Pipeline Products by Regulatory Path 11

3.5 Arteriotomy Closure Devices – Pipeline Products by Estimated Approval Date 12

3.6 Arteriotomy Closure Devices – Ongoing Clinical Trials 13

4 Arteriotomy Closure Devices – Pipeline Products under Development by Companies 14

4.1 Arteriotomy Closure Devices Companies – Pipeline Products by Stage of Development 14

4.2 Arteriotomy Closure Devices – Pipeline Products by Stage of Development 15

5 Arteriotomy Closure Devices Companies and Product Overview 16

5.1 Aporo Biomedical, Inc. (Inactive) Company Overview 16

5.1.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 CardioDex Ltd (Inactive) Company Overview 17

5.2.1 CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 CloSys Corp Company Overview 18

5.3.1 CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 CPC of America Inc Company Overview 19

5.4.1 CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 Dextera Surgical Inc Company Overview 20

5.5.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.6 Harvard University Company Overview 21

5.6.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 21

5.7 Mayo Clinic Company Overview 22

5.7.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 22

5.8 ProMed Inc Company Overview 23

5.8.1 ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.9 Rex Medical LP Company Overview 24

5.9.1 Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview 24

5.10 University of Rochester Company Overview 26

5.10.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 26

5.11 Vascular Closure Systems Inc Company Overview 27

5.11.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.12 Venock Inc Company Overview 30

5.12.1 Venock Inc Pipeline Products & Ongoing Clinical Trials Overview 30

6 Arteriotomy Closure Devices- Recent Developments 33

6.1 Mar 18, 2021: JenaValve Technology Welcomes Jane Metcalf as Vice President, Regulatory Affairs and Quality 33

6.2 Feb 05, 2021: Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021 33

6.3 Feb 04, 2021: Cardinal Health Earnings Preview 34

6.4 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience 34

6.5 Aug 07, 2020: Conformal Medical raises $85m to fund stroke prevention technology 34

6.6 Jul 15, 2020: Cardiva Medical raises funds to commercialise vascular closure systems 35

7 Appendix 37

7.1 Methodology 37

7.2 About GlobalData 40

7.3 Contact Us 40

7.4 Disclaimer 40

Table

Arteriotomy Closure Devices – Pipeline Products by Stage of Development

Arteriotomy Closure Devices – Pipeline Products by Segment

Arteriotomy Closure Devices – Pipeline Products by Territory

Arteriotomy Closure Devices – Pipeline Products by Regulatory Path

Arteriotomy Closure Devices – Pipeline Products by Estimated Approval Date

Arteriotomy Closure Devices – Ongoing Clinical Trials

Arteriotomy Closure Devices Companies – Pipeline Products by Stage of Development

Arteriotomy Closure Devices – Pipeline Products by Stage of Development

Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Femoral Artery Closure Device – Product Status

Femoral Artery Closure Device – Product Description

CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

EpiClose Plus – Product Status

EpiClose Plus – Product Description

CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview

CloSys HD – Product Status

CloSys HD – Product Description

CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview

MedClose – Product Status

MedClose – Product Description

Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview

X-Port Vascular Access Closure Device – Product Status

X-Port Vascular Access Closure Device – Product Description

Harvard University Pipeline Products & Ongoing Clinical Trials Overview

Access-Closure Device – Product Status

Access-Closure Device – Product Description

Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview

Left Atrial Appendage Closure Device – Product Status

Left Atrial Appendage Closure Device – Product Description

ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview

Large Hole Closure Device – Product Status

Large Hole Closure Device – Product Description

Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview

Auto-Close Vascular Sealing System – Product Status

Auto-Close Vascular Sealing System – Product Description

Large Bore Closer Vascular Sealing System – Product Status

Large Bore Closer Vascular Sealing System – Product Description

University of Rochester Pipeline Products & Ongoing Clinical Trials Overview

Vascular Closure Device – Product Status

Vascular Closure Device – Product Description

Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

FastSeal Bioabsorbable Vascular Access Closure System – Product Status

FastSeal Bioabsorbable Vascular Access Closure System – Product Description

FastSeal Bioabsorbable Vascular Access Closure System – 18 Fr – Product Status

FastSeal Bioabsorbable Vascular Access Closure System – 18 Fr – Product Description

FastSeal Self – Closing Nitinol Clip System – Product Status

FastSeal Self – Closing Nitinol Clip System – Product Description

FastSeal Swellable And Bioabsorbable Tubular Plug System – Product Status

FastSeal Swellable And Bioabsorbable Tubular Plug System – Product Description

Venock Inc Pipeline Products & Ongoing Clinical Trials Overview

Venock Vascular Closure Device – Product Status

Venock Vascular Closure Device – Product Description

Venock Inc – Ongoing Clinical Trials Overview

Venock Vascular Closure Device – A Study to Evaluate the Efficacy of Large Bore Venous Closure System in Subjects with High Pressure Conditions for Closure of Large Bore Arterial Perforations

Glossary

Figures

Arteriotomy Closure Devices – Pipeline Products by Stage of Development

Arteriotomy Closure Devices – Pipeline Products by Segment

Arteriotomy Closure Devices – Pipeline Products by Territory

Arteriotomy Closure Devices – Pipeline Products by Regulatory Path

Arteriotomy Closure Devices – Pipeline Products by Estimated Approval Date

Arteriotomy Closure Devices – Ongoing Clinical Trials

Frequently asked questions

Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cardiovascular Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more